Related references
Note: Only part of the references are listed.Tumor suppression by p53 without apoptosis and senescence: conundrum or rapalog-like gerosuppression?
Mikhail V. Blagosklonny
AGING-US (2012)
Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging
Mikhail V. Blagosklonny
AGING-US (2012)
Akt and p53 are potential mediators of reduced mammary tumor growth by Chloroquine and the mTOR inhibitor RAD001
Christian R. Loehberg et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
Tongyuan Li et al.
CELL (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
CHRONIC INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN BY RAPAMYCIN MODULATES COGNITIVE AND NON-COGNITIVE COMPONENTS OF BEHAVIOR THROUGHOUT LIFESPAN IN MICE
J. Halloran et al.
NEUROSCIENCE (2012)
Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome
Leslie B. Gordon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C-Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival
Fresnida J. Ramos et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression
Olga V. Leontieva et al.
AGING-US (2011)
Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
Vladimir N. Anisimov et al.
CELL CYCLE (2011)
The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia
Philip Saunders et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Tumor Suppressor and Aging Biomarker p16INK4a Induces Cellular Senescence without the Associated Inflammatory Secretory Phenotype
Jean-Philippe Coppe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Four faces of cellular senescence
Francis Rodier et al.
JOURNAL OF CELL BIOLOGY (2011)
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Richard A. Miller et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Darren J. Baker et al.
NATURE (2011)
The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function
Kai Yang et al.
NATURE IMMUNOLOGY (2011)
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
Lioubov G. Korotchkina et al.
AGING-US (2010)
With TOR, Less Is More: A Key Role for the Conserved Nutrient-Sensing TOR Pathway in Aging
Pankaj Kapahi et al.
CELL METABOLISM (2010)
S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response
Keng Po Lai et al.
EMBO JOURNAL (2010)
Stressin' Sestrins take an aging fight
Andrei V. Budanou et al.
EMBO MOLECULAR MEDICINE (2010)
Paradoxical suppression of cellular senescence by p53
Zoya N. Demidenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Rapamycin: The Cure for all that Ails
Paul Hasty
JOURNAL OF MOLECULAR CELL BIOLOGY (2010)
Transcriptional Regulation by p53
Rachel Beckerman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Rapamycin Prevents Early Onset of Tumorigenesis in an Oral-Specific K-ras and p53 Two-Hit Carcinogenesis Model
Ana R. Raimondi et al.
CANCER RESEARCH (2009)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin Pathway
Wuqiang Zhu et al.
CIRCULATION (2009)
Inactivation of p53 and Pten promotes invasive bladder cancer
Anna M. Puzio-Kuter et al.
GENES & DEVELOPMENT (2009)
Rapamycin Delays Tumor Development in Murine Livers by Inhibiting Proliferation of Hepatocytes with DNA Damage
Laura Elisa Buitrago-Molina et al.
HEPATOLOGY (2009)
Specific Activation of mTORC1 by Rheb G-protein in Vitro Involves Enhanced Recruitment of Its Substrate Protein
Tatsuhiro Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular mechanisms of mTOR-mediated translational control
Xiaoju Max Ma et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Colin Selman et al.
SCIENCE (2009)
Targeting the MDM2-p53 interaction for cancer therapy
Sanjeev Shangary et al.
CLINICAL CANCER RESEARCH (2008)
Transcriptional control of human p53-regulated genes
Todd Riley et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity
Lynette Moore et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2007)
Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53
Chung-Han Lee et al.
EMBO JOURNAL (2007)
Targeting mammalian target of rapamycin (mTOR) for health and diseases
Chi Kwan Tsang et al.
DRUG DISCOVERY TODAY (2007)
Stress and mTORture signaling
J. H. Reiling et al.
ONCOGENE (2006)
A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria
LG Fong et al.
SCIENCE (2006)
Tumor suppression and normal aging in mice with constitutively high p53 activity
SM Mendrysa et al.
GENES & DEVELOPMENT (2006)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
The coordinate regulation of the p53 and rnTOR pathways in cells
ZH Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Modulation of mammalian life span by the short isoform of p53
B Maier et al.
GENES & DEVELOPMENT (2004)
Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging
A Matheu et al.
GENES & DEVELOPMENT (2004)
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
HB Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
Y Zhang et al.
NATURE CELL BIOLOGY (2003)
ATM and related protein kinases: Safeguarding genome integrity
Y Shiloh
NATURE REVIEWS CANCER (2003)
'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally
I García-Cao et al.
EMBO JOURNAL (2002)
REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species
LW Ellisen et al.
MOLECULAR CELL (2002)
p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation
LE Horton et al.
ONCOGENE (2002)
p53 mutant mice that display early ageing-associated phenotypes
SD Tyner et al.
NATURE (2002)
Regulation of PTEN transcription by p53
V Stambolic et al.
MOLECULAR CELL (2001)
Share Paper
